Fertility and Sterility is a prestigious peer-reviewed journal dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier Science Inc, this journal has been a cornerstone of scientific discourse since its inception in 1950 and is set to continue its influential coverage of cutting-edge research until 2024. Boasting an impressive impact factor, Fertility and Sterility is ranked among the top-tier journals in its category, holding Q1 status in both Obstetrics and Gynecology and Reproductive Medicine. With Scopus rankings placing it in the 97th and 96th percentiles respectively, the publication serves as a vital resource for researchers, clinicians, and students who seek to advance their understanding of fertility issues and reproductive health. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and innovative solutions to the complex challenges in reproduction, empowering professionals and scholars to make meaningful contributions in their fields.

Reproductive Biology and Endocrinology, published by BMC, is a distinguished open-access journal established in 2003, catering to researchers and professionals in the interdisciplinary fields of reproductive biology, endocrinology, and related biomedical sciences. With a notable impact in 2023, the journal has achieved Q1 rankings in Obstetrics and Gynecology, Reproductive Medicine, and Endocrinology, alongside a Q2 ranking in Developmental Biology, establishing itself as a pivotal source of high-quality research and insights. The journal's commitment to freely accessible research promotes knowledge dissemination across its domains, which is crucial for advancing understanding of reproductive health and endocrine mechanisms. With a robust Scopus ranking showcasing its relevance—17th out of 209 in Obstetrics and Gynecology, and 8th out of 90 in Reproductive Medicine—it serves as an essential resource for academics and clinicians alike, facilitating innovative research and fostering collaboration within the global scientific community.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, published by Wiley, is a leading journal in the field of obstetrics and gynecology that has been disseminating high-quality research since its inception. With an ISSN of 1341-8076 and an E-ISSN of 1447-0756, this journal thrives on contributing to this specialized area of medicine, showcasing innovations and advancements essential for practitioners and scholars alike. Notably, it holds a commendable Impact Factor reflective of its Q2 ranking in both Medicine and Obstetrics and Gynecology categories for 2023, placing it in the 55th percentile among its peers according to Scopus. The journal covers a wide array of topics pertinent to contemporary medical practices and research in Australia and beyond, aiming to foster interdisciplinary dialogue and advance clinical practices. Researchers, professionals, and students will find it an invaluable resource, featuring rigorous peer-reviewed articles that shed light on emerging trends, clinical guidelines, and groundbreaking studies. As it continues to converge on pivotal medical issues up until 2024, JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH stands poised to make a lasting impact in the realm of women's health.

HUMAN REPRODUCTION is a prestigious academic journal published by Oxford University Press, dedicated to advancing the field of reproductive medicine. With an impressive impact factor highlighting its significance, the journal ranks in the top quartile (Q1) for Obstetrics and Gynecology, Rehabilitation, and Reproductive Medicine, showcasing its crucial role in disseminating high-quality research. Founded in 1986, it has become a key resource for researchers, practitioners, and students interested in cutting-edge developments and innovative practices in human reproduction. Despite not currently offering open access, the journal continues to publish a wealth of peer-reviewed articles that contribute substantially to clinical knowledge and practice. With Scopus rankings placing it among the top journals in its categories, HUMAN REPRODUCTION remains an essential platform for discussion and dissemination of vital findings impacting reproductive health globally.

The Journal of Gynecology Obstetrics and Human Reproduction, published by Elsevier Masson, is an esteemed platform dedicated to advancing knowledge in the fields of gynecology, obstetrics, and reproductive medicine. Established in 2016, this journal has quickly gained prominence, currently holding a Q2 ranking in both Obstetrics and Gynecology, as well as Reproductive Medicine, as of 2023. With its base in France, the journal aims to provide crucial insights and the latest research findings, catering to a diverse audience of researchers, professionals, and students. The journal operates under the open access model, ensuring that high-quality articles are freely accessible, fostering collaboration and knowledge exchange among practitioners and scholars. With a broad scope covering various facets of women's health, the Journal of Gynecology Obstetrics and Human Reproduction is committed to contributing to the advancement of research and practice in these vital fields.

Jornal Brasileiro de Reprodução Assistida is a prominent academic journal focusing on the latest advancements in reproductive medicine, published by the Sociedade Brasileira de Reprodução Assistida (SBRA). With an ISSN of 1517-5693 and an E-ISSN of 1518-0557, this journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of obstetrics and gynecology. Notably recognized within the Q2 category for Obstetrics and Gynecology, it ranks #91 out of 209 in Scopus, placing it in the 56th percentile among its peers. The journal serves as a platform for disseminating innovative research and clinical practices related to assisted reproduction, fostering collaboration and knowledge sharing among professionals in Brazil and beyond. Although currently not an open-access journal, it remains committed to enhancing the scientific discourse in reproductive health, reflecting its vision of supporting advances in healthcare through rigorous peer-reviewed studies. Explore the pivotal contributions made in this field from 2000 to the present, and stay abreast of transformative developments that are shaping reproductive science.

Welcome to the Turkish Journal of Obstetrics and Gynecology, a premier publication dedicated to advancing the field of reproductive health and women's care. Published by GALENOS PUBL HOUSE since 2004, this journal serves as an essential resource for researchers, clinicians, and students interested in the latest developments in obstetrics and gynecology. With an impact factor that reflects its growing influence, the journal is currently classified in the Q3 quartile within its category, ranking 114 out of 209 in Scopus, placing it in the 45th percentile. Offering a truly Open Access platform, it provides a global audience with immediate access to critical research findings. The journal encompasses a broad scope of topics aimed at improving health outcomes for women, with a focus on evidence-based practice. In recent years, from 2016 to 2024, it has significantly contributed to the regional and international discourse in the field, making it an invaluable resource for practitioners and scholars alike. Join us in exploring the vital issues and innovations shaping obstetrics and gynecology today.

Reproduction and Fertility is a premier academic journal published by BIOSCIENTIFICA LTD, dedicated to advancing knowledge in the fields of reproductive sciences, obstetrics, gynecology, and related areas. Established with a focus on delivering high-quality research, this journal has quickly ascended in prominence, achieving a commendable Q2 ranking in multiple categories, including Embryology, Obstetrics and Gynecology, Reproductive Medicine, and Urology, as of 2023. With an E-ISSN of 2633-8386, Reproduction and Fertility aims to provide a valuable platform for researchers, professionals, and students alike, offering insights into the latest discoveries and innovations in reproductive health. Although currently not an open-access journal, it remains committed to disseminating important findings that can influence clinical practices and policy-making worldwide. Operating from its headquarters in Bristol, United Kingdom, the journal serves as an essential resource for anyone invested in understanding and improving reproductive health outcomes through rigorous academic research.

Frontiers in Reproductive Health is a leading open-access journal published by Frontiers Media SA in Switzerland, dedicated to advancing the field of reproductive health through high-quality research and comprehensive reviews. With a commitment to fostering an interdisciplinary dialogue, this journal covers an array of topics including epidemiology, family practice, obstetrics and gynecology, and reproductive medicine. As of 2023, it ranks in the Q3 quartile in Epidemiology, Q1 in Family Practice, and Q2 in both Obstetrics and Gynecology and Reproductive Medicine, reflecting its significance and growing influence in these areas. Researchers and professionals can benefit from the journal's wide distribution and open access policy, which facilitates the sharing of knowledge and enhances the visibility of their work. By embracing innovative studies and harnessing the talents of both established scholars and emerging voices, Frontiers in Reproductive Health plays a crucial role in shaping the future of reproductive health research and practice.

GYNECOLOGICAL ENDOCRINOLOGY is a prestigious open-access journal published by Taylor & Francis Ltd, focusing on the dynamic fields of endocrinology, obstetrics, and gynecology. With its ISSN of 0951-3590 and E-ISSN of 1473-0766, this journal provides a vital platform for the dissemination of high-quality research and advancements in gynecological endocrinology since its inception in 1987. Notably, it attained an Open Access status in 2023, enhancing its reach and accessibility to researchers and practitioners worldwide. The journal is renowned for its rigorous peer-review process and holds significant standing with a Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Endocrinology, Diabetes, and Metabolism, as of 2023. It is indexed with commendable Scopus ranks in various medical domains, offering a reliable resource for current methodologies and future directions in gynecological health. With the growing emphasis on women's health and endocrinological research, GYNECOLOGICAL ENDOCRINOLOGY serves as an essential repository for innovative studies, clinical insights, and emerging therapeutic strategies, making it an invaluable resource for researchers, clinicians, and students alike.